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Arachidonic acid metabolism was examined in a se· 
ries of strongly malignant murine fibrosarcoma cell 
lines and in a series of weakly malignant lines isolated 
from the same tumors. The cells were examined in 
the unstimulated state and after stimulation with 12· 
0-tetradecanoyl phorbol acetate (TPA), laminln or fl. 
bronectin. All 3 agents were known from previous 
studies to Induce adherence and motility in the mu· 
rine fibrosarcoma cells. When the cells were prela· 
belled with 3H-arachidonic acid, all 3 agents stimulated 
the release of radioactivity into the supernatant fluids. 
The response to TPA was rapid while the response 
Was slower but sustained when either laminin or flbro· 
nectin was used as the stimulating agent. This is of 
interest because TPA induces a rapid but transient 
adherence response in the same cells while laminin 
and fibronectin induce a slow, sustained response. Ex· 
amination by radioimmunoassay procedures indicated 
that both control cells and stimulated cells were able 
to produce a variety of lipoxygenase and cyclooxygen· 
ase metabolites. In quantitative terms, the strongly 
malignant cells were more active than their weak· 
ly malignant counterparts. They released greater 
amounts of radioactivity into the supernatant fluid 
and produced a greater quantity of arachidonic acid 
metabolites, particularly prostaglandin E2, than did 
the corresponding weakly malignant cells. This is of 
interest because previous studies have shown that 
While both the strongly and weakly malignant cells 
respond in the adherence assay to TPA, laminin and 
fibronectin, only the strongly malignant cells demon· 
Strate directional motility (chemotaxis and hap· 
totaxis). 
Arachidonic acid metabolism accompanies stimulus-
coupled responses in several types of cells (Habenicht 
et al., 1981; Schrey and Rubin, 1979; Butler-Gralla et 
al., 1983; Wertz and Mueller 1978, 1980; Levine and 
liassid, 1977) and has been extensively investigated in 
leukocytes (see Goldman and Goetz!, 1983 for a re-
~iew). When leukocytes are stimulated with chemotac-
hc factors, arachidonic acid is released from phos-
Pholipid pools and is metabolized through both the 
lipoxygenase and cyclooxygenase pathways. Products 
of the lipoxygenase pathway (including monohy~rox­
Yeicosatetraenoic acids [HETEs] and leukotnenes 
[LTs]) are thought to be positive mediators of the 
chemotactic response as these agents will stimulate 
cell-to-substrate adherence, cell-to-cell aggregation, 
enzyme release and chemotaxis in leukocytes (Gold-
man and Goetz!, 1983). Cyclooxygenase products (i.e., 
Prostaglandins [PGs]), on the other hand, are thought 
to serve as negative modulators, limiting the cellu!ar 
response to stimulation (O'Fiaherty et al., 1979; Rtv-
kin et al., 1975; Kunkel et al., 1979; Fantone et al., 
l983b). Arachidonic acid metabolites may play a role 
in the chemotactic response of non-leukocytic cells as 
Well. Mensing and Czarnetski (1984) showed that LTB4 
Was chemotactic for normal fibroblasts and studies in 
our laboratory showed that the same agent stimulate~ 
adhesiveness in Walker carcinosarcoma cells (Varam, 
1985). The response in the Walker cells was very 
similar to that stimulated by chemotactic peptides. 
Other studies have shown that cyclooxygenase metab-
olites (i.e., E-series prostaglandins and prostacyclin) 
inhibit chemotactic factor-induced adherence and 
chemotaxis in the same Walker cells (Fantone et a/. , 
l983a; Mokashi et al., 1983; Varani and Perone, 
1985). 
In the present studies we investigated arachidonic 
acid metabolism in a series of strongly and weakly 
malignant murine fibrosarcoma cells. The cells were 
examined in the unstimulated state and following stim-
ulation with 3 different ligands (i.e. , 12-0-tetradeca-
noyl phorbol acetate [TPA], laminin and fibronectin) 
that induce adherence and motility in these and other 
cells (Lowe et al., 1978; Yamasaki eta/., 1979; Cas-
tagna et a/., 1979; Koffler et a/., 1981; Schor et a/., 
1981; Gauss-Muller et a/., 1980; McCarthy et a/., 
1983, 1984; Varani and Fantone, 1982; Lee et a/., 
1984; Situ eta/., 1984; Varani eta/., l985a,b). All 3 
ligands induced the release of 3H-arachidonic acid from 
prelabelled cells and a conversion of arachidonic acid 
into a variety of end products. These results show that 
in the murine fibrosarcoma cells, as in several other 
cell types previously investigated (Butler-Gralla et a/. , 
1983; Levine and Hassid, 1977; Wertz and Mueller, 
1980) metabolism of arachidonic acid accompanies re-
sponse to stimulation with TPA. They show, further-
more, that laminin and fibronectin-high-molecular-
weight glycoproteins which may have a very different 
mode of action from TPA-also stimulate arachidonic 
acid metabolism in responsive cells. 
MATERIAL AND METHODS 
Cells 
The strongly and weakly malignant cell lines used in 
this study were obtained from three different chemi-
cally-induced murine fibrosarcomas. The tumors from 
which the cell lines arose have been designated as 
tumors l.O, l.l and 1.2. The strongly malignant cell 
lines have been designated 1.0/Ll, l.l, 1.1/clone 16, 
and 1.2. Weakly malignant cell lines were obtained 
from each of the 3 tumors. These cell lines have been 
designated as 1.0/anti-Br, 1.1/anti-Br, and 1.2/anti-Br. 
The isolation and characterization of these populations 
have been described in previous reports (Varani et a/., 
1919a,b, 1980, 1983b). In the present study, all of the 
cell lines were maintained under identical conditions 
which included growth in RPMI-1640 medium supple-
mented with 10% fetal bovine serum at 37°C in 5% 
C02/95% air. The cells were subcultured by trypsini-
zation as necessary. Prior to use in these studies all of 
the cell lines were shown to be free of mycoplasma 
contamination by incubation in mycoplasma broth and 
on mycoplasma agar. 
1To whom reprint requests should be sent. 
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Stimulating agents 
Two large glycoprotein molecules, laminin and fi-
bronectin, were used as stimulating agents in this study. 
Laminin was prepared in our laboratory by the method 
of Timpl et al. (1979) or purchased from Bethesda 
Research (Gaithersburg, MD). The commercially ob-
tained reagent was also purified by the same method. 
Purity of the laminin was checked by SDS-polyacryl-
amide gel (5%) electrophoresis run under reducing 
conditions. Only 2 major protein bands-at Mr = 
200,000 and 400,000-were seen. When examined by 
means of an enzyme-linked immunosorbent assay 
(ELISA) (Varani et al., J983a), the Jaminin reacted 
with anti-laminin antibodies undiluted or at dilutions 
up to I: 1,000,000 but did not react with anti-fibronec-
tin antibodies (provided as a gift by Dr. R. Wiggins, 
Department of Medicine, University of Michigan) or 
with anti-type IV collagen antibodies (provided as a 
gift by Dr. H. Furthmayr, Department of Pathology. 
Yale University). When a cell attachment assay was 
used as an indicator of biological activity (Varani et 
al., 1983a), the laminin was effective at 0.5-1.0 J.Lg 
per 35-mm diameter dish. 
Human plasma fibronectin was purchased from Be-
thesda Research or from Sigma (St. Louis, MO). Both 
commercial preparations showed a single major pro-
tein band when examined by SDS-polyacrylamide gel 
electrophoresis. The fibronectin preparations reacted 
with anti-fibronectin antibodies by ELISA but did not 
react with the anti-laminin antibodies. Cell attachment 
activity was detectable with concentrations as low as 2 
J.Lg per 35-mm dish. 
We also used the biologically-active phorbol ester, 
12-0-tetradecanoyl phorbol acetate (TPA) as a stimu-
lating agent. The TPA was obtained from Sigma and 
frozen as a 1.6 X 10-2M solution in dimethylsulfox-
ide. It was diluted in culture medium at the time of 
use. 
Arachidonic acid metabolism 
3H-arachidonic acid (87 Ci/mmol), obtained from 
New England Nuclear, Boston, MA, was used to mea-
sure arachidonic acid release from the control and 
stimulated cells. Freshly-harvested cells were labelled 
by preincubation for 2 hr with 1 J.LCi of the 3H-arachi-
donic acid per 5 x 107 cells in 5 ml RPMI-1640 culture 
medium supplemented with 10% fetal bovine serum. 
Incubation was carried out at 3rc and 5% C02 • 
During the labelling procedure, the cells were kept in 
tubes and maintained in suspension by gentle shaking. 
The distribution of the radioactivity within the labelled 
cells was determined by subjecting the labelled cells to 
a Folch extraction (Folch et al., 1957) and analyzing 
the chloroform-soluble fraction by thin-layer chroma-
tography using a modification of the solvent system 
described by Skipski et al. (1964). Depending on the 
cell type and the experiment, we were able to obtain 
1-2 X 105 counts per minute (CPM) of 3H-arachidonic 
acid incorporated per I x 106 cells. Nearly all of the 
incorporated material was found in the chloroform-
soluble phase and wtien this material was analyzed, 
the radioactivity was found in bands co-migrating with 
phosphatidylcholine, phosphatidylinositol, phosphati-
dylserine and phosphatidylethanolamine. Less than 
10% of the chloroform-soluble radioactivity was in 
bands which co-migrated with free fatty acids, triglyc-
erides and cholesterol esters. After labelling, the cells 
were centrifuged and washed twice in culture medium 
to remove unincorporated 3H-arachidonic acid. The 
cells were then aliquoted into tubes, stimulated with 
the appropriate agent and incubated at 3rc and 5% 
C02. At various times thereafter, 200-J.Ll samples (2 x 
106 cells) were removed from the tubes. The samples 
were added to 300 J.Ll of phosphate-buffered saline and 
the cells separated from the supernatant fluid by cen-
trifugation. Radioactivity in the supernatant fluid was 
then determined using a {3-scintillation counter. 
Cyclooxygenase and lipoxygenase metabolites of ar-
achidonic acid were quantitated in the control and 
stimulated cells. The cyclooxygenase products mea-
sured were PGE2, PGF2 ... and 6-keto PGF 1 .. (a pros-
tacyclin metabolite). Lipoxygenase products measured 
included 5-HETE, 12-HETE and LTC4 . For these as-
says, the cells were harvested, washed 4 times in 
serum-free culture medium and incubated at 5 X 106 
cells per ml of serum-free medium. At various subse-
quent times, the supernatant fluids (for cyclooxygen-
ase metabolites) or the cells and supernatant fluids (for 
lipoxygenase products) were harvested, extracted and 
assayed. The extraction procedure involved precipita-
tion of the protein with acetonitrile, and extraction of 
most neutral lipids from the acidified acetonitrile frac-
tion with petroleum ether. After removal of the ether 
layer, the remaining aqueous phase was extracted twice 
with ethyl acetate and dried in air. The residue was 
redissolved in phosphate-buffered saline containing 
0.1% gelatin and assayed for the various metabolites 
using radioimmunoassay (RIA) procedures. Assays for 
cyclooxygenase metabolites were performed with an-
tibodies and labelled ligands obtained from NEN. The 
limits of sensitivity for the 3 assays were 0.9-3.8 pg/ 
tube. Cross-reactivity of each antibody to related pros-
taglandins was low (less than 1.8%). The LTC4 assay 
was also carried out using a NEN assay kit. The limit 
of sensitivity for this assay was 3.7 pg/reaction tube. 
The antibody to LTC4 cross-reacted with LTD4 (55%) 
and LTE4 (8,.6%) but showed low cross-reactivity (less 
than I~) wtth LTB4 , mono-HETEs and various pros-
taglandms. The 5-HETE and 12-HETE assays were 
carried out with kits available from Seragen (Boston, , 
MA). The .limit of sensitivity of the 5-HETE assay was 
8 pg/reactton tube. The antibody used in this assay 
cross-reacted with 5, 15-DiHETE ( 10%) and to a lesser 
extent (3-5%) with LTB4 , LTC4 , LTD4 and LTE4 but 
showed low cross-reactivity (less than 0.6%) with other 
mono-HETEs and various prostaglandins. The 12-
HETE assay had a limit of sensitivity of 2 pg/reaction 
tube but showed extremely low cross-reactivity (less 
than 0.3%) with other mono-HETES, leukotrienes and 
prostaglandins. The actual assay procedures were car-
ried out by the Ligand Core Laboratory at the Michi-
gan Diabetes Research and Training Center (Ann 
Arbor, MI). 
RESULTS 
Arachidonic acid metabolism in the strongly and 
weakly malignant cells 
Cells were prelabelled with 3H-arachidonic acid as 
described in "Material and Methods." They were then 
examined for their ability to release radioactivity into 
the culture medium under unstimulated conditions and 
after stimulation with lam in in, fibronectin or TPA (Fig. 
1). In the absence of stimulation there was a slow 
release of radioactivity into the culture medium from 
all of the cells. The amount of radioactivity found in 
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FIGURE I - Release of radioactivity from 3H-arachidonic acid-prelabcllcd cells. The cells were pretreated with 3H-ar-
achidonic acid as described in "Material and Methods" and then incubated in culture medium with and without stimulation. 
The values shown arc the amount of radioactivity recovered from the supernatant tluid at various subsequent times. Values 
arc averages of duplicate tubes in a single experiment where the duplicate values were nearly always within 10% of the 
mean values. Cells from each tumor were examined together between 3-7 times with very similar results. (Unstimulated, 
·-·; 1.6 X I0-8 MTPA, /::,-£::,; 100!-lg/mllaminin, 0-0; 100/lg/ml fibronectin, D-0). 
the supernatant fluid increased over the 90-min obser-
Vation period and accounted for 0.5-1.5% of the total. 
With cell lines from 2 of the 3 tumors ( 1.1 and 1.2) 
the strongly malignant cells were much more active 
than their weakly malignant counterparts. With the 
third tumor ( 1.0), both the strongly and weakly malig-
~ant cells released comparable amounts of radioactiv-
ItY-similar to the amounts released by the weakly 
rnalignant cells from the other 2 tumors. 
Stimulation of the prelabelled cells with either Iami-
nin, fibronectin or TPA led to an increased release of 
radioactivity into the supernatant fluids from all cells 
(Fig. 1). With laminin and fibronectin, significant dif-
ferences between the treated and control cells were not 
observed at the earliest time points (5 and 15 min) but 
Were observed after longer incubation (30, 60 and 90 
rnin). TPA also stimulated arachidonic acid release 
f~om all of the cell types. The pattern, however, was 
dtfferent from that observed with laminin and fibro-
nectin. The radioactivity released from the TPA-stim-
ul~ted cells reached a peak early (30 min after 
Shrnulation) and then either levelled off or decreased. 
l'he decrease in extracellular radioactivity could indi-
cate reincorporation of the released arachidonic acid 
or a metabolite produced from it. 
Radioimmunoassay procedures were used to quanti-
!ate arachidonic acid metabolites produced by the var-
Ious cell lines. For this purpose, the cells were har-
vested from culture and incubated under serum-free 
conditions with or without stimulation for 4 hr. The 
supernatant fluids (for cyclooxygcnase metabolites) or 
the cells and supernatant fluids (for lipoxygenase me-
tabolites) were then extracted as described in "Mate-
rial and Methods." Cyclooxygcnase data arc shown in 
Table I and lipoxygenase data in Table II. To summa-
rize the results of the cyclooxygenase analyses, PGE2 
was the major metabolite identified with all of the 
cells, although significant amounts of 6-keto PGF 1,. 
and PGF2, were also detected. The quantities of me-
tabolites produced by the cells varied with cell type 
and reflected the amounts of radioactivity released 
from prelabelled cells (compare Table I and Fig. l). 
The strongly malignant cells from tumor 1.0 produced 
slightly higher levels of prostaglandins than did the 
weakly malignant cells from the same tumor. The 
strongly malignant cells from the other 2 tumors pro-
duced much higher levels than the corresponding weak-
ly malignant cells. 
In regards to lipoxygenase metabolites, there were 
no consistent or dramatic differences between the 
strongly and weakly malignant cells (Table II). The 
amount of LTC4 obtained from the strongly malignant 
cells in the unstimulated state was slightly greater than 
the amount obtained from the corresponding weakly 
malignant cells. The relative magnitudes of the differ-
ences were much smaller than those observed in the 
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TABLE I- CYCLOOXYGENASE METABOLITES OF ARACHIDONIC ACID PRODUCED BY THE STRONGLY AND WEAKLY MALIGNANT CELLS 
Cell line Stimulation 
Amoun~roduced (ng/5 x I cells/4 hr) 1 
PGE2 6-kcto PGF 1,. PGF2,. 
1.0/LI None 5.7 ± 0.2 0.7 ± 0.1 0.6 ± 0.1 
TPA2 5.6 ± 0.1 2.5 ± 0.5 0.6 ± 0.1 
Laminin3 3.6 ± 0.3 0.5 ± 0.1 0.2 ± 0.2 
Fibronectin4 1.5 ± 0.2 0.5 ± 0.1 0.1 ± 0.1 
1.0/anti-Br None 4.1 ± 0.3 < 0.1 0.4 ± 0.2 
TPA 5.6 ± 0.4 < 0.1 0.6 ± 0.1 
Laminin 12.2 ± 0.6 < 0.1 I. I ± 0.3 
Fibronectin 14.3 ± 0.4 < 0.1 0.5 ± 0.1 
1.1 None 22.3 ± 1.3 1.8 ± 0.1 5.1 ± 0.8 
TPA 21.1 ± 1.0 2.6 ± 0.3 4.8 ± 1.3 
Laminin 18.6 ± 0.9 1.5 ± 0.2 3.8 ± 0.8 
Fibronectin 29.3 ± 0.7 1.8 ± 0.2 3.5 ± 2.0 
I. II clone 16 None 32.0 ± 3.1 2.1 ± 0.3 3.5 ± 0.6 
TPA 35.5 ± 1.9 2.0 ± 0.4 3.8 ± 0.7 
Laminin 39.7 ± 1.6 2.6 ± 0.3 3.7 ± 1.2 
Fibronectin 27.4 ± 1.0 2.4 ± 0.2 4.4 ± 0.7 
1.1/anti-Br None 3.9 ± 0.9 < 0.1 0.1 ± 0.1 
TPA 4.4 ± 1.7 < 0.1 0.2 ± 0.1 
Laminin 2.3 ± 1.0 < 0.1 0.1 ± 0.1 
Fibronectin 5.0 ± 1.7 < 0.1 0.1 ± 0.1 
1.2 None 12.8 ± 1.5 4.2 ± 0.5 0.5 ± 0.1 
TPA 24.4 ± 2.3 1.1 ± 0.1 0.5 ± 0.1 
Laminin 13.0 ± 1.0 1.5±0.1 0.7 ± 0.1 
Fibronectin 11.7 ± 1.3 1.7 ± 0.2 0.5 ± 0.1 
1.2/anti-Br None 1.4 ± 0.2 < 0.1 0.1 ± 0.1 
TPA 2.3 ± 0.3 < 0.1 0.1 ± 0.1 
Laminin 1.7 ± 0.1 < 0.1 0.2 ± 0.1 
Fibronectin 1.7 ± 0.1 < 0.1 0.2 ± 0.1 
1Valucs shown arc averages ± standard errors of the mean. PGE, values li>r the 1.2 and 1.2/anti-B' cells are based on 6 independent experiments. Other values are based on 3-independcnt experiments.-21.6 x 10-• M. 
-
3 100 pg per ml.-4 100 pg per mi. 
TARL•: II- UPOXYGENASE METABOLITES OF ARACHIDONIC ACID arachidonic acid release studies and assays for prosta-PRODUCED BY THE STRONGLY AND WEAKLY MALIGNANT CELLS glandin production. Likewise, no consistent pattern 
Am<JUndfroduccd was seen with any of the 3 stimulating agents. In some 
Cell line Stimulation (pg/5 x I 'cells/4 hr) 1 instances, there was a dramatic stimulation of LTC4 5-HETE 12-HETE LTC4 production (for example in the l.O/L1 and 1.0/anti-Br 
1.0/Ll None ND5 ND 196 ± 66 cells treated with laminin or fibronectin) but in other 
TPA2 ND ND 172 ± 80 instances, the same agent had no effect or actually 
Laminin3 ND ND 1,790 ± 18 resulted in a decrease in production (for example, in 
Fibronectin4 ND ND 1,517 ± 99 the I. I cells). 
1.0/ None ND ND 105 ± 76 
anti-B' TPA ND ND 205 ± 64 
DISCUSSION Laminin ND ND 752 ± 108 
Fibronectin ND NO 2,820 ± 251 Arachidonic acid metabolism has been extensively 1.1 None NO NO 263 ± 82 investigated in relation to leukocyte chemotaxis. When TPA NO NO 177 ±54 
Laminin NO NO 148 ± 44 leukocytes are stimulated with chemotactic factors, 
Fibronectin NO NO 109 ± 70 t~e.re is a release of arachidonic acid from phospho-
1.11 None NO NO 138 ± 66 hp1d pools and a stimulation of arachidonic acid me-
clone 16 TPA NO NO 1,210 ± 132 tabolism through the Iipoxygenase and cyclooxygenase 
Laminin NO NO 169 ± 70 pathways. Several of the arachidonic acid metabolites 
Fibronectin NO NO 162 ± 76 produced as a result of stimulation have potent media-1.11 None NO NO 104 ± 62 tor function and are thought to play a role in the anti-B' TPA NO NO 252 ± 73 biological responses to chemotactic stimulation (Gold-Laminin NO NO 266 ± 70 
Fibronectin NO NO 1,210 ± 140 man and Goetz!, 1983). Although most other systems 
1.2 None 31 ± 7 20 ±I 253 ± 75 have not been as widely investigated as leukocytes, 
TPA 43 ± 3 45 ± II 1,070 ± 140 arachidonic acid metabolism is known to accompany 
Laminin . 46 ± 2 74 ± 8 212 ± 78 stimulus-coupled responses in a variety of cells (Ha-
Fibronectin NO NO 175 ± 24 benicht eta/., 1981; Schrey and Rubin, 1979; Butler-
1.2/ None 51 ± 3 <10 173 ± 161 Gralla et al., 1983; Wertz and Mueller, 1980; Levine 
anti-B' TPA 58± 10 <10 63 ± 71 and Hassid, 1977). Laminin 85 ± 7 30 ± 5 221 ± 73 In the present study we investigated arachidonic acid Fibronectin NO NO 137 ± 72 
metabolism in a series of murine fibrosarcoma cell 
1 Values shown are average ± the differences between mean values and lines. The cells that were used included 4 strongly individual values in a single experjment. The metabolites were measured 
malignant lines from 3 different carcinogen-induced on two separate occasions with similar results.-2 1.6 x 10- 8 M.-3 100 pg 
per ml.-4 100 pg per ml.-5 Not done. tumors and 3 weakly malignant variant lines isolated 
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from the same 3 tumors. The cells were examined in 
the unstimulated state and after treatment with laminin, 
fibronectin or TPA. All 3 agents stimulated increased 
arachidonic acid release from prelabelled cells. With 
TPA the response was rapid while a slower but sus-
tained response was observed with laminin and fibro-
nectin. This is of interest because a very similar 
relationship exists in regard to biological responses. In 
these tumor cells (Varani et at., 1985a) TPA induces a 
rapid but transient adherence response but has no long-
term effect on either cell attachment or spreading. In 
contrast, both 1aminin and fibronectin induce a slow 
but sustained increase in cell attachment and spreading 
(Varani et at., J985a,b). Thus, the kinetics of the 
biological response to the stimulating agents and the 
kinetics of arachidonic acid release stimulated by the 
same agents are in accord. This allows for the specu-
l~tion that the 2 are related. Whether specific metabo-
lites of arachidonic acid are essential mediators of the 
biological responses induced by these 3 agents remains 
to be seen. This will have to await a more complete 
9ualitative and quantitative assessment of the meta?o-
htes produced by the cells and a direct demonstratiOn 
that these metabolites can elicit biological responses 
similar to those produced by the stimulating agents. 
This has not yet been done although previous studies 
have shown that products of the Iipoxygenase system 
stimulate adhesiveness in the Walker 256 carcinosar-
coma cells (Varani, 1985) and chemotaxis in fibro-
blasts (Mensing and Czarnetski, 1984). 
During the course of our studies it became clear that 
the strongly malignant cells were metabolically more 
active with regard to arachidonic acid metabolism than 
their weakly malignant counterparts. What makes these 
differences of interest is the observation that similar 
differences exist in regard to cell motility. The strongly 
malignant cells are much more motile than the weakly 
malignant ones. This is observed in the absence. of a 
gradient (Situ et at., 1984) as well as in the presence 
of a chemotactic or haptotactic gradient (Orr et at., 
1981; Varani et at., 1985a). It is interesting, further-
more, that when the strongly malignant cells from the 
3 different tumors are compared among themselves, 
the 1.0/Ll cells are less motile than the other 3 lines 
(Situ et at., 1984; Varani eta/., 1985a). Thus, while 
there appears to be no precise quantitative relationship 
between arachidonic acid metabolism and a response 
in the adherence assay, such a relationship may indeed 
exist between arachidonic acid metabolism and cell 
motility. 
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